Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upc
Trial projected to be initiated shortly following receipt of drug product by trial sites NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or…
adminJuly 23, 2024